If you look at the top pharma nations around the globe, you’ll see India just following closely behind the United States and China, and that right there is a big achievement in itself. The pharma industry right here in India is growing crazy fast, like the estimations are that this industry will reach the $130 billion mark by 2030, and that too, super easily. Though it isn’t possible without the big pharma companies playing their part in it, and that is precisely why we’re here with this list of the Top 10 Biggest Pharmaceutical Companies In India 2025, to talk about it a little more. Here we go then.
1. Sun Pharmaceutical Industries
Sun Pharma is the oldest and biggest company in India as far as the pharmaceutical industry is concerned. And if you want to learn how big it is, then let us say it comes with a market capitalization of ₹4.08 lakh crore. It was started in 1983 in the city of Mumbai, and it works everywhere, like medicine sold in over a hundred countries and manufacturing well over 30 billion doses a year. Generics, special medicines, and those key Active Pharmaceutical Ingredients (APIs) are brought into their sights. In simple terms, the company is into neurology, skin, heart, and cancer therapeutics. Sun Pharma has 43 manufacturing facilities spread across the globe and, thus, is a very big company, being ranked fourth among specialty generics globally.
2. Divi’s Laboratories
Next in line is Divi’s Laboratories, a star located in Hyderabad and engaged in making Active Pharmaceutical Ingredients and intermediates. According to some estimates in the year 2025, its valuations range between ₹1.55 lakh crore and ₹1.75 lakh crore. They export APIs primarily to large global brands, and that is quite significant. What contributes to their brand value is the research-heavy approach and impeccable quality standards. They do not directly sell medicines to the common man, but are essential for the global medicine supply framework.
3. Cipla Ltd
A name like Cipla truly requires no introduction. Cipla was founded in 1935. In the year 2025, the company has a market capitalization of about ₹1.17 to 1.18 lakh crore. They went into the spotlight for their low-cost HIV/AIDS medicines for Africa; really speaking, it is a noble cause. Presently, Cipla is leading in medicines for respiratory issues, HIV/AIDS, and chronic illnesses such as diabetes. Cipla operates in more than 150 countries, keeping medicines cheap and life-saving.
4. Dr. Reddy’s Laboratories
Then there is Dr. Reddy’s, another Hyderabad-based pharma giant enjoying the glory of 2025, yet valued at nearly ₹1.4 lakh crore. The company is big in the export of generics, biosimilars, and highly specialized medicines to over 60 countries, mainly in the US and Europe. Dr. Reddy’s invests heavily with an R&D focus on large therapeutics such as cancer treatments and biologics. If there is any company going on the cutting edge, it surely is Dr. Reddy’s.
5. Torrent Pharmaceuticals
Based on some reports out there, Torrent Pharma stands tall in 2025 with a valuation of approximately ₹1.02 to 1.07 Lakh crores. From Ahmedabad, they cater especially to medicines for heart ailments, brain disorders, and diabetes-things that are so common these days in India. So, with such stringent markets as the US and Europe, Torrent has only been increasing its R&D capabilities year after year. Hence, when it comes to acute stability and focus on chronic diseases, Torrent stands out, particularly.
6. Mankind Pharma
For 2025, multiple sources have placed the market value of Mankind Pharma Company between ₹98,000 crore and ₹1.01 lakh crore. It is their super popular name because of products like Prega News or Manforce, with medicines for cardio-related issues, diabetes, and antibiotics, among others, followed extensively all over India, in big cities and smaller towns alike. Presently, the company is moving into international markets. What a super big development!
7. Zydus Lifesciences
Zydus Lifesciences, previously Cadila Healthcare, grabs a firm hold in 2025 with a market value of approximately ₹88,000 to ₹93,000 crore. The Ahmedabad-based company got the attention with ZyCoV-D, India’s first DNA-based COVID-19 vaccine, must we say, a tremendous achievement right there! They work on the vaccines, biosimilars, and generic drugs for exports to lots of countries. Huge bets on biotech and global approvals have hit the growth path never before experienced by this company.
8. Lupin
Lupin, Mumbai based, is still going strong in 2025 with a market valuation of around ₹89,000 crore. Making drugs for breathing disorders, heart ailments, and diabetes is their main niche. Lupin enjoys a comfortable presence in tough markets in the US, Europe, and Japan, where the standards are very strict. Their R&D centers work in the area of complex generics and biosimilars, which are much sought after. If you really want a company that has crossed the continental boundaries, Lupin is your name.
9. Aurobindo Pharma
Another Hyderabad star, Aurobindo Pharma, is valued between ₹65,000 and ₹66,000 crore in 2025. They are among the leading exporters of generic drugs from India, oh, and that too mainly to the US and Europe. They largely interact in antibiotics, antiretrovirals, and psychiatric medicines, and also in biosimilars and injectables. Having several manufacturing plants approved by world regulators, Aurobindo provides an undeniable edge for its homeland in the international scene.
10. Abbott India
Last but definitely not least, Abbott India is the only multinational on this list, with a 2025 market value of around ₹59,000 crore. Global giant Abbott Laboratories has been present in India since 1944. Their operations are concentrated on medicines for chronic conditions, nutrition, and metabolic disorders, with a portfolio of more than 600 products designed to cater to Indian requirements. From multi-specialty pharmaceuticals to nutritional products with brand presence, Abbott India knows how to make its presence in the local market.
Conclusion
That’s about it for now. There are many more up-and-coming names in the pharma industry of India, but if we’re just talking about the biggest ones out there, well, we laid out the names right in front of you today. These are the very companies that played and are still playing a big part in making this industry grow.
